Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
3.510
-0.180 (-4.88%)
At close: Jun 5, 2026, 4:00 PM EDT
3.700
+0.190 (5.41%)
After-hours: Jun 5, 2026, 7:17 PM EDT
Treace Medical Concepts Market Cap
Treace Medical Concepts has a market cap or net worth of $227.7 million as of June 5, 2026. Its market cap has decreased by -45.89% in one year.
Market Cap
227.70M
Enterprise Value
247.45M
1-Year Change
-45.89%
Ranking
Category
Stock Price
$3.51
Market Cap Chart
Since the IPO on April 23, 2021, Treace Medical Concepts's market cap has decreased from $889.74M to $227.70M, a decrease of -74.41%. That is a compound annual growth rate of -23.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 239.38M | 53.34% |
| Dec 31, 2025 | 156.11M | -66.32% |
| Dec 31, 2024 | 463.49M | -41.06% |
| Dec 29, 2023 | 786.37M | -38.37% |
| Dec 30, 2022 | 1.28B | 28.74% |
| Dec 31, 2021 | 991.14M | 11.40% |
| Apr 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 908 Devices | 333.52M |
| Electromed | 304.04M |
| Quantum-Si incorporated | 278.73M |
| Sight Sciences | 250.29M |
| Profound Medical | 247.28M |
| RxSight | 211.12M |
| TriSalus Life Sciences | 202.67M |
| Lucid Diagnostics | 194.59M |